Immunogenicity and safety of concomitant administration of meningococcal serogroup B (4CMenB) and serogroup C (MenC-CRM) vaccines in infants: A phase 3b, randomized controlled trial-Reference-Cited by-同舟云学术

Immunogenicity and safety of concomitant administration of meningococcal serogroup B (4CMenB) and serogroup C (MenC-CRM) vaccines in infants: A phase 3b, randomized controlled trial

Published:2017-04 Issue:16 Volume:35 Page:2052-2059
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

P. Safadi Marco Aurelio,Martinon-Torres Federico,Weckx Lily Yin,Moreira Edson Duarte,da Fonseca Lima Eduardo Jorge,Mensi Ilhem,Calabresi Marco,Toneatto Daniela

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference28 articles.

1. Effect of vaccines on bacterial meningitis worldwide;McIntyre;Lancet,2012

2. Global epidemiology of meningococcal disease;Harrison;Vaccine,2009

3. Molecular epidemiology of Neisseria meningitidis serogroup B in Brazil;de Filippis;PLoS One,2012

4. The current situation of meningococcal disease in Latin America and recommendations for a new case definition from the Global Meningococcal Initiative;Safadi;Expert Rev Vaccines,2013

5. Outbreak of Neisseria meningitidis C in a Brazilian oil refinery involving an adjacent community;Liphaus;Enferm Infecc Microbiol Clin,2013

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety and immunogenicity of co-administered meningococcal serogroup B (4CMenB) vaccine: A literature review;Human Vaccines & Immunotherapeutics;2023-08

2. Translating meningococcal serogroup B vaccines for healthcare professionals;Expert Review of Vaccines;2021-06-20

3. Health impact and cost-effectiveness of introducing the vaccine (Bexsero) against MenB disease into the Brazilian immunization programme;Vaccine;2019-10

Meningococcal Group B Vaccine For The Prevention Of Invasive Meningococcal Disease Caused By Neisseria meningitidis Serogroup B

;Infection and Drug Resistance;2019-10

5. Immunogenicity of the pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) administered concomitantly with the meningococcal serogroup B (4CMenB) vaccine in infants: A post-hoc analysis in a phase 3b, randomised, controlled trial;Vaccine;2019-08